Canada markets open in 7 hours 48 minutes

Fusion Pharmaceuticals Inc. (FUSN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
21.42+0.10 (+0.47%)
At close: 04:00PM EDT
21.42 -0.00 (-0.01%)
After hours: 05:59PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
1,915
2,068
1,461
1,440
0
Operating Expenses
Research Development
53,099
70,103
58,895
56,357
17,191
Selling General and Administrative
29,986
31,197
30,600
27,098
20,744
Total Operating Expenses
83,085
101,300
89,495
83,455
37,935
Operating Income or Loss
-81,170
-99,232
-88,034
-82,015
-37,935
Interest Expense
5,166
5,166
1,801
0
-
Total Other Income/Expenses Net
-1,032
762
-1,775
469
-38,114
Income Before Tax
-81,901
-94,110
-89,449
-81,165
-75,722
Income Tax Expense
-1,670
787
-1,837
-118
2,611
Income from Continuing Operations
-80,231
-94,897
-87,612
-81,047
-78,333
Net Income
-80,231
-94,897
-87,612
-81,047
-78,333
Net Income available to common shareholders
-80,231
-94,897
-87,612
-81,047
-79,715
Basic EPS
-1.61
-
-2.00
-1.90
-3.62
Diluted EPS
-1.61
-
-2.00
-1.90
-3.62
Basic Average Shares
58,512
-
43,749
42,599
22,033
Diluted Average Shares
58,512
-
43,749
42,599
22,033